Literature DB >> 21625232

An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia.

T Herold, V Jurinovic, K H Metzeler, A-L Boulesteix, M Bergmann, T Seiler, M Mulaw, S Thoene, A Dufour, Z Pasalic, M Schmidberger, M Schmidt, S Schneider, P M Kakadia, M Feuring-Buske, J Braess, K Spiekermann, U Mansmann, W Hiddemann, C Buske, S K Bohlander.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21625232     DOI： 10.1038/leu.2011.125

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  28 in total

1.  In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia.

Authors:  Suliman A Alsagaby; Danish Iqbal; Iqrar Ahmad; Harun Patel; Shabir Ahmad Mir; Yahya Awaji Madkhali; Atif Abdulwahab A Oyouni; Yousef M Hawsawi; Fahad A Alhumaydhi; Bader Alshehri; Wael Alturaiki; Bader Alanazi; Manzoor Ahmad Mir; Waleed Al Abdulmonem
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

2.  Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.

Authors:  Tobias Herold; Stephanie Schneider; Klaus H Metzeler; Martin Neumann; Luise Hartmann; Kathryn G Roberts; Nikola P Konstandin; Philipp A Greif; Kathrin Bräundl; Bianka Ksienzyk; Natalia Huk; Irene Schneider; Evelyn Zellmeier; Vindi Jurinovic; Ulrich Mansmann; Wolfgang Hiddemann; Charles G Mullighan; Stefan K Bohlander; Karsten Spiekermann; Dieter Hoelzer; Monika Brüggemann; Claudia D Baldus; Martin Dreyling; Nicola Gökbuget
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

3.  Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.

Authors:  Junyan Lu; Ester Cannizzaro; Fabienne Meier-Abt; Sebastian Scheinost; Peter-Martin Bruch; Holly Ar Giles; Almut Lütge; Jennifer Hüllein; Lena Wagner; Brian Giacopelli; Ferran Nadeu; Julio Delgado; Elías Campo; Maurizio Mangolini; Ingo Ringshausen; Martin Böttcher; Dimitrios Mougiakakos; Andrea Jacobs; Bernd Bodenmiller; Sascha Dietrich; Christopher C Oakes; Thorsten Zenz; Wolfgang Huber
Journal:  Nat Cancer       Date:  2021-07-01

Review 4.  Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia.

Authors:  Marion Lapierre; Audrey Castet-Nicolas; Delphine Gitenay; Stéphan Jalaguier; Catherine Teyssier; Caroline Bret; Guillaume Cartron; Jérôme Moreaux; Vincent Cavaillès
Journal:  J Hematol Oncol       Date:  2015-03-04       Impact factor: 17.388

5.  ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.

Authors:  Sarah Weiler; Jolaolu A Ademokun; John D Norton
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

6.  One-step extrapolation of the prediction performance of a gene signature derived from a small study.

Authors:  Ling-Yi Wang; Wen-Chung Lee
Journal:  BMJ Open       Date:  2015-04-17       Impact factor: 2.692

7.  Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions.

Authors:  Sally Yepes; Maria Mercedes Torres; Rafael E Andrade
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

8.  Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia.

Authors:  G Palermo; D Maisel; M Barrett; H Smith; G Duchateau-Nguyen; T Nguyen; R-F Yeh; A Dufour; T Robak; D Dornan; M Weisser
Journal:  Blood Cancer J       Date:  2015-10-02       Impact factor: 11.037

9.  A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.

Authors:  Gregory Lazarian; Shanye Yin; Elisa Ten Hacken; Tomasz Sewastianik; Mohamed Uduman; Alba Font-Tello; Satyen H Gohil; Shuqiang Li; Ekaterina Kim; Heather Joyal; Leah Billington; Elizabeth Witten; Mei Zheng; Teddy Huang; Mariano Severgnini; Valerie Lefebvre; Laura Z Rassenti; Catherine Gutierrez; Katia Georgopoulos; Christopher J Ott; Lili Wang; Thomas J Kipps; Jan A Burger; Kenneth J Livak; Donna S Neuberg; Fanny Baran-Marszak; Florence Cymbalista; Ruben D Carrasco; Catherine J Wu
Journal:  Cancer Cell       Date:  2021-03-08       Impact factor: 31.743

10.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.